2.39
price up icon3.91%   0.09
after-market Handel nachbörslich: 2.39
loading

Finanzdaten der Absci Corp-Aktie (ABSI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
36.26%
0.378
0.593 1.179 0.665 1.701
Operating Expenses
4.55%
30.53
31.99 28.91 30.44 30.60
Benefits Costs and Expenses
6.61%
28.98
31.03 27.53 29.63 29.06
Costs And Expenses
6.61%
28.98
31.03 27.53 29.63 29.06
Operating Income/Loss
3.95%
-30.15
-31.39 -27.73 -29.77 -28.89
Nonoperating Income/Loss
62.51%
1.552
0.955 1.379 0.812 1.534
Income/Loss From Continuing Operations Before Tax
6.03%
-28.60
-30.44 -26.35 -28.96 -27.36
Income Tax Expense/Benefit
20.61%
0.104
0.131 -0.004 0.021 0.037
Income/Loss From Continuing Operations After Tax
6.09%
-28.71
-30.57 -26.35 -28.98 -27.40
Net Income/Loss
6.09%
-28.71
-30.57 -26.35 -28.98 -27.40
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
12.68%
143.77
127.59 124.46 1.5748 113.61
Diluted Average Shares
12.68%
143.77
127.59 124.46 1.5748 113.61
Basic Earnings Per Share
16.67%
-0.20
-0.24 -0.21 -0.26 -0.24
Diluted Earnings Per Share
16.67%
-0.20
-0.24 -0.21 -0.26 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):